Thought Leadership
Email Page
5 Lessons We Can Learn from FDA’s First Biosimilar Review
January 8, 2015
Jeff Overley
Law360

Axinn Counsel Stacie Ropka was quoted in Jeff Overley’s article, “5 Lessons We Can Learn from FDA’s First Biosimilar Review,” which appeared on Law360.

Click here to access the article. A Law360 subscription is required.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.